rxstat › Shortages › Ropinirole

Ropinirole shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Ropinirole products are in shortage in Canada (5 of 23 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Aug 10, 2026.
Products affected
5 / 23
In shortage since
Nov 22, 2019
Est. full return
Aug 10, 2026
Reports on file
76
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
TEVA-ROPINIROLE
1MG · TABLET · TEVA CANADA LIMITED
DIN 02316854 · since May 6, 2026, est. end Aug 10, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-ROPINIROLE
0.25MG · TABLET · TEVA CANADA LIMITED
DIN 02316846 · since Apr 30, 2026, est. end Aug 10, 2026 · Disruption of the manufacture of the drug.
Active shortage
JAMP-ROPINIROLE
1.0MG · TABLET · JAMP PHARMA CORPORATION
DIN 02352346 · since Mar 27, 2020, est. end Dec 30, 2022 · Disruption of the manufacture of the drug.
Active shortage
JAMP-ROPINIROLE
2.0MG · TABLET · JAMP PHARMA CORPORATION
DIN 02352354 · since Nov 22, 2019, est. end Dec 30, 2022 · Disruption of the manufacture of the drug.
Active shortage
JAMP-ROPINIROLE
0.25MG · TABLET · JAMP PHARMA CORPORATION
DIN 02352338 · since Nov 22, 2019, est. end Dec 30, 2022 · Disruption of the manufacture of the drug.
To be discontinued
SPC-ROPINIROLE
5MG · TABLET · SUN PHARMA CANADA INC
DIN 02314088
Resolved
SPC-ROPINIROLE
0.25MG · TABLET · SUN PHARMA CANADA INC
DIN 02314037 · ended Apr 8, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-ROPINIROLE
5MG · TABLET · TEVA CANADA LIMITED
DIN 02316870 · ended Nov 12, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-ROPINIROLE
1MG · TABLET · TEVA CANADA LIMITED
DIN 02316854 · ended Nov 12, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-ROPINIROLE
2MG · TABLET · TEVA CANADA LIMITED
DIN 02316862 · ended Nov 12, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-ROPINIROLE
0.25MG · TABLET · TEVA CANADA LIMITED
DIN 02316846 · ended Nov 12, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-ROPINIROLE
0.25MG · TABLET · TEVA CANADA LIMITED
DIN 02316846 · ended Oct 10, 2024 · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Ropinirole is currently affected by 5 active shortage reports filed with Health Canada by TEVA CANADA LIMITED, JAMP PHARMA CORPORATION.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Ropinirole is classified under “DOPAMINERGIC AGENTS” (ATC N04BC).

Recent changes

Common questions

When will Ropinirole be back in stock in Canada?

The latest manufacturer estimate is Aug 10, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Ropinirole in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (dopaminergic agents)

Widespread shortageRasagiline4 of 7 reported products affected · est. return Jul 31, 2026Partial shortageApomorphine1 of 6 reported products affectedPartial shortageCarbidopa Levodopa4 of 21 reported products affected · est. return Nov 30, 2026Partial shortageEntacapone1 of 4 reported products affected · est. return Jul 20, 2026Partial shortagePramipexole Dihydrochloride4 of 40 reported products affected · est. return Sep 4, 2026Partial shortageSelegiline1 of 3 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.